Pharmaceuticals Companies By Roe

Return On Equity
ROEEfficiencyMarket RiskExp Return
1NVO Novo Nordisk AS
0.89
(0.23)
 1.81 
(0.41)
2LLY Eli Lilly and
0.65
(0.15)
 1.90 
(0.29)
3SIGA SIGA Technologies
0.58
(0.05)
 4.34 
(0.23)
4ZTS Zoetis Inc
0.47
(0.04)
 1.30 
(0.05)
5HROWL Harrow Health 8625
0.45
 0.09 
 0.28 
 0.03 
6COLL Collegium Pharmaceutical
0.43
(0.14)
 2.35 
(0.33)
7NVS Novartis AG ADR
0.29
(0.22)
 0.99 
(0.22)
8MRK Merck Company
0.28
(0.17)
 1.20 
(0.20)
9CORT Corcept Therapeutics Incorporated
0.26
 0.30 
 2.83 
 0.85 
10AMPH Amphastar P
0.24
(0.03)
 2.59 
(0.08)
11HRMY Harmony Biosciences Holdings
0.23
 0.02 
 3.93 
 0.07 
12GSK GlaxoSmithKline PLC ADR
0.22
(0.25)
 1.47 
(0.36)
13JNJ Johnson Johnson
0.21
(0.11)
 0.79 
(0.09)
14RDY Dr Reddys Laboratories
0.19
(0.20)
 1.32 
(0.26)
15RPRX Royalty Pharma Plc
0.17
(0.12)
 1.00 
(0.12)
16AZN AstraZeneca PLC ADR
0.17
(0.27)
 1.53 
(0.41)
17PBH Prestige Brand Holdings
0.13
 0.16 
 1.26 
 0.20 
18JAZZ Jazz Pharmaceuticals PLC
0.12
 0.05 
 2.08 
 0.11 
19INVA Innoviva
0.0997
(0.02)
 1.12 
(0.02)
20PAHC Phibro Animal Health
0.0655
 0.10 
 2.31 
 0.22 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income. For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.